1. Home
  2. DPRO vs SCLX Comparison

DPRO vs SCLX Comparison

Compare DPRO & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DPRO
  • SCLX
  • Stock Information
  • Founded
  • DPRO 1998
  • SCLX 2011
  • Country
  • DPRO Canada
  • SCLX United States
  • Employees
  • DPRO N/A
  • SCLX N/A
  • Industry
  • DPRO Aerospace
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DPRO Industrials
  • SCLX Health Care
  • Exchange
  • DPRO Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • DPRO 38.9M
  • SCLX 35.7M
  • IPO Year
  • DPRO N/A
  • SCLX N/A
  • Fundamental
  • Price
  • DPRO $4.98
  • SCLX $15.72
  • Analyst Decision
  • DPRO Strong Buy
  • SCLX Strong Buy
  • Analyst Count
  • DPRO 2
  • SCLX 3
  • Target Price
  • DPRO $6.50
  • SCLX $367.50
  • AVG Volume (30 Days)
  • DPRO 7.7M
  • SCLX 264.5K
  • Earning Date
  • DPRO 08-19-2025
  • SCLX 08-19-2025
  • Dividend Yield
  • DPRO N/A
  • SCLX N/A
  • EPS Growth
  • DPRO N/A
  • SCLX N/A
  • EPS
  • DPRO N/A
  • SCLX N/A
  • Revenue
  • DPRO $4,716,450.00
  • SCLX $50,710,000.00
  • Revenue This Year
  • DPRO $66.19
  • SCLX $89.26
  • Revenue Next Year
  • DPRO $101.07
  • SCLX $203.95
  • P/E Ratio
  • DPRO N/A
  • SCLX N/A
  • Revenue Growth
  • DPRO 7.90
  • SCLX 7.79
  • 52 Week Low
  • DPRO $1.55
  • SCLX $3.60
  • 52 Week High
  • DPRO $7.31
  • SCLX $49.00
  • Technical
  • Relative Strength Index (RSI)
  • DPRO 52.84
  • SCLX 69.99
  • Support Level
  • DPRO $4.76
  • SCLX $12.59
  • Resistance Level
  • DPRO $5.43
  • SCLX $15.59
  • Average True Range (ATR)
  • DPRO 0.63
  • SCLX 2.11
  • MACD
  • DPRO -0.15
  • SCLX 0.23
  • Stochastic Oscillator
  • DPRO 21.18
  • SCLX 79.15

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: